Baseline Asthma Impairment and Risk Questionnaire (AIRQ™) Control Level is Associated with Future Risk of Exacerbations - 01/02/21
Doi : 10.1016/j.jaci.2020.12.201
David Beuther 1, Kevin Murphy, MD 2, Robert Zeiger, MD PhD FAAAAI 3, Robert Wise 4, William McCann, MD FAAAAI 5, Joan Reibman 6, Maureen George, PhD RN AE-C 7, Ileen Gilbert 8, James Eudicone 8, Hitesh Ghandi 8, Karin Coyne 9, Melissa Ross 9, Bradley Chipps 10
1 National Jewish Health, Denver, CO
2 Boys Town National Research Hospital, Boys Town, NE
3 Departments of Allergy and Research and Evaluation, Kaiser Permanente Southern California, San Diego and Pasadena, CA
4 Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
5 Allergy Partners, Asheville, NC
6 New York University School of Medicine, New York, NY
7 Columbia University School of Nursing, New York, NY
8 AstraZeneca, Wilmington, DE
9 Evidera, Bethesda, MD
10 Capital Allergy & Respiratory Disease Center, Sacramento, CA
148
El texto completo de este artículo está disponible en PDF.Esquema
© 2020
Publicado por Elsevier Masson SAS.
Vol 147 - N° 2S
P. AB47 - février 2021 Regresar al número
Artículo precedente
- Effects of Sex and Age on Characteristics of United States Patients With Severe Asthma
- Njira Lugogo, Elizabeth Judson, Erin Haight, Frank Trudo, Bradley Chipps, Jennifer Trevor, Chris Ambrose
- Perception of burden of oral and inhaled corticosteroid adverse effects by asthmatic patients
- Vickram Tejwani, Hsing-Yuan Chang, Annie Tran, Tonya Winders, Rachael Moloney
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?